Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Myocardial IschemiaHeart Valve Diseases
Interventions
DEVICE

Cytosorb

A cytoadsorbent cardridge (Cytosorb) will be added to the extra-corporeal circuit (CPB).

Trial Locations (1)

1011

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors
lead

Centre Hospitalier Universitaire Vaudois

OTHER

NCT02775123 - Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass | Biotech Hunter | Biotech Hunter